Sign in
4

Changes in Ownership

Adaptive Biotechnologies Corp Filed Acc 0001209191-20-058197

Chief Financial Officer sold 30,000 shares at an average $49.16 ($1,474,705)

  • Chief Financial Officer acquired 30,000 shares (option exercise)

From the SEC's structured data for this filing

Trades in this filing

Cohen Chad M · Chief Financial Officer

Table I: Non-derivative

4 lines
Date Transaction Shares Price Value Owned after D/I
2020-11-09 Exercise or conversion : show line 1 in the form +30,000 $6.32 $189,600 31,000 D
2020-11-09 Sale : show line 2 in the form −17,151 $48.67 $834,739 13,849 D
2020-11-09 Sale : show line 3 in the form −11,089 $49.63 $550,347 2,760 D
2020-11-09 Sale : show line 4 in the form −1,760 $50.92 $89,619 1,000 D
Open-market sales · 30,000 sh · avg $49.16 · $1,474,705

Table II: Derivative

1 line
Date Transaction Shares Owned after D/I
2020-11-09 Exercise or conversion : show line 5 in the form Stock Option (Right To Buy) −30,000 520,000 D
Loading xslF345X03/doc4.xml…